Australia markets open in 7 hours 15 minutes

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2100-0.0400 (-1.78%)
At close: 04:00PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,839
-7,382
-4,107
-4,766
-3,420
Depreciation & amortisation
218
351
252
208
200
Stock-based compensation
841
982
1,259
779
1,332
Change in working capital
1,256
229
883
-3,493
-580
Accounts receivable
-83
357
-278
-333
392
Inventory
1,264
915
296
-2,762
-735
Accounts payable
27
-593
908
-538
119
Other working capital
869
-3,371
-1,453
-7,142
-2,290
Other non-cash items
-
353
321
97
-105
Net cash provided by operating activities
869
-3,234
-1,417
-6,903
-2,276
Cash flows from investing activities
Investments in property, plant and equipment
-
-137
-36
-239
-14
Acquisitions, net
-
-
-
0
-137
Other investing activities
-
-
-49
-
-
Net cash used for investing activities
0
-137
-85
-239
-151
Cash flows from financing activities
Debt repayment
-156
-286
-264
-800
-216
Common stock issued
-
-
0
11,452
1,992
Other financing activities
-
157
-
-85
-94
Net cash used provided by (used for) financing activities
-187
34
237
11,216
2,017
Net change in cash
682
-3,339
-1,276
4,083
-415
Cash at beginning of period
3,940
6,973
8,249
4,166
4,581
Cash at end of period
4,622
3,634
6,973
8,249
4,166
Free cash flow
Operating cash flow
869
-3,234
-1,417
-6,903
-2,276
Capital expenditure
-
-137
-36
-239
-14
Free cash flow
869
-3,371
-1,453
-7,142
-2,290